Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | P4HB | P07237 | 1/20 | 0.53 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.53 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | CASP7 | P55210 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12651482 | 0.84 | P4HB (0.63) | P4HBPDIA4PDIA3TSHRHSD17B10 | |
| SCHEMBL12651491 | 0.84 | P4HB (0.63) | P4HBPDIA4PDIA3TSHRHSD17B10 | |
| SCHEMBL12651644 | 0.83 | KMT2A (0.53) | MEN1CYP3A4KMT2AP4HBPDIA4 | |
| SCHEMBL8946122 | 0.83 | TSHR (0.59) | P4HBPDIA4PDIA3TSHRLMNA | |
| SCHEMBL20633976 | 0.83 | P4HB (0.61) | P4HBPDIA4PDIA3TSHRLMNA | |
| SCHEMBL7744449 | 0.83 | TSHR (0.59) | MEN1CYP3A4KMT2AP4HBPDIA4 | |
| SCHEMBL8945980 | 0.82 | TSHR (0.56) | P4HBPDIA4PDIA3TSHRLMNA | |
| SCHEMBL20635289 | 0.82 | TSHR (0.56) | P4HBPDIA4PDIA3TSHRLMNA | |
| SCHEMBL2338993 | 0.82 | TSHR (0.56) | P4HBPDIA4PDIA3TSHRLMNA | |
| SCHEMBL8654501 | 0.82 | P4HB (0.61) | P4HBPDIA4PDIA3TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383088-B2 | Coumestan-like antioxidants and UV absorbants | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20100330009-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | CIBA CORPORATION (US) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330009-A1 | COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS | TYR, NQO1, SIRT3 | MEN1 3538/4885CYP3A4 61/4885KMT2A 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.